Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer Shares Rise 4% After Xarelto Wins U.S. FDA Approval
Bayer Shares Rise 4% After Xarelto Wins U.S. FDA Approval
Bayer Shares Rise 4% After Xarelto Wins U.S. FDA Approval
Submitted by
admin
on November 7, 2011 - 9:24am
Source:
Bloomberg
News Tags:
FDA
Bayer
Xarelto
bloodthinners
Headline:
Bayer Shares Rise 4% After Xarelto Wins U.S. FDA Approval
Do Not Allow Advertisers to Use My Personal information
